Daniel Podzamczer
Expertise in
2
conditions

Daniel Podzamczer

CT, ES 
Expertise in
2
conditions
CT, ES 

Overview

Daniel Podzamczer practices practicing medicine in Spain.

Mr. Podzamczer is highly rated in 2 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Anal Cancer, Atherosclerosis, and Cervical Dysplasia.

He is actively involved in clinical research, co-authoring 138 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

CT, Spain
Other Locations
Barcelona, CT, Spain
L'hospitalet De Llobregat, CT, Spain
Badalona, CT, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

An Open-Label, Multi-Centre, Randomised Study to Investigate Integrase Inhibitor Versus Boosted Protease Inhibitor Antiretroviral Therapy for Patients With Advanced HIV Disease
An Open-Label, Multi-Centre, Randomised Study to Investigate Integrase Inhibitor Versus Boosted Protease Inhibitor Antiretroviral Therapy for Patients With Advanced HIV Disease
Enrollment Status: Completed
Publish Date: December 17, 2025
Intervention Type: Drug
Study Drugs: Biktarvy, Symtuza
Study Phase: Phase 3
Doravirine Concentrations and Antiviral Activity in Genital Fluids in HIV-1 Infected Individuals
Doravirine Concentrations and Antiviral Activity in Genital Fluids in HIV-1 Infected Individuals
Enrollment Status: Completed
Publish Date: July 06, 2022
Intervention Type: Drug
Study Drugs: Doravirine, Descovy
Study Phase: Phase 2
Doravirine Concentrations and Antiviral Activity in Cerebrospinal Fluid in HIV-1 Infected Individuals
Doravirine Concentrations and Antiviral Activity in Cerebrospinal Fluid in HIV-1 Infected Individuals
Enrollment Status: Completed
Publish Date: April 28, 2022
Intervention Type: Drug
Study Drugs: Doravirine, Descovy
Study Phase: Phase 3
View 2 Less Clinical Trials

138 Total Publications

Author Correction: Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial.
Author Correction: Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial.
Journal: Nature communications
Published: April 27, 2026

Frequently Asked Questions about Daniel Podzamczer

Is Daniel Podzamczer a top-rated expert for HIV/AIDS?

MediFind is an objective health platform that identifies experts based on real-world data. Daniel Podzamczer is classified as an Elite expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Daniel Podzamczer participate in research or clinical trials?

Yes. Daniel Podzamczer has published 138 articles and abstracts on conditions like HIV/AIDS. You can view a list of Daniel Podzamczer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Podzamczer's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile